Alexza Pharma (ALXA) Reports Q1 Loss of $0.16
Tweet
Share
E-mailGet Alerts ALXA Hot Sheet
Join SI Premium – FREE
Alexza Pharma (NASDAQ: ALXA) reported Q1 EPS of ($0.16), versus ($0.02) reported last year.
For earnings history and earnings-related data on Alexza Pharma (ALXA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
- Goldman Sachs Upgrades Drax Group Plc. (DRX:LN) (DRXGY) to Buy
- UBS Downgrades JINS Holdings Inc (3046:JP) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
